Computed tomography features and clinicopathological characteristics of gastric glomus tumor.

BMC Gastroenterol

Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1, East Jianshe Road, Zhengzhou, 450052, Henan Province, China.

Published: April 2022

AI Article Synopsis

  • Gastric glomus tumor (GGT) is a rare tumor in the stomach that can be hard to tell apart from other similar tumors because doctors don’t see it often.
  • In a study with 21 patients, most had benign (not cancerous) GGT, while only one was malignant (cancerous), and it mainly occurred in older adults.
  • CT scans showed that benign GGTs appeared as smooth, round masses in the stomach, whereas the malignant one was irregular and invaded other areas, looking much different.

Article Abstract

Background: Gastric glomus tumor (GGT) is a rare neoplasm that is difficult to distinguish from other gastric submucosal tumors due to a lack of diagnostic experience. The goal of this study was to better understand GGT by looking at its clinicopathological features, computed tomography (CT) features, and differential diagnosis.

Methods: The clinical data and CT findings of 21 pathologically confirmed GGT patients were examined. The clinical characteristics and CT findings of benign GGT were compared to gastric stromal tumors (GST) (n = 30) and heterotopic pancreas (n = 30).

Results: The 21 cases included six males and fifteen females ranging in age from 42 to 64 years. The lesions were found in the gastric body in four cases and the antrum in seventeen. GGT was diagnosed as benign in 20 cases and malignant in one. In benign cases, the glomus cells were small, uniform, showed perivascular hemangiopericytoma‑like or solid nest‑like structures. Obvious mitotic figures were observed in the malignant case. SMA staining was positive in the tumor cells. A quasi-round or round solid mass protruded into the gastric cavity in 20 benign cases, with a clear and smooth edge. The long to short diameter ratio was 1.01 ± 0.15. All of the benign cases had obvious enhancement, with homogeneous enhancement in ten cases and heterogeneous enhancement in ten cases, as well as central filling enhancement in 12 cases. The ratio of CT value of lesion to abdominal aorta in arterial phase and venous phase were (0.41 ± 0.11) and (0.81 ± 0.20), which were significantly higher than GST and heterotopic pancreas. The irregular mass broke through the gastric wall and invaded liver with poorly defined boundary and internal necrosis, heterogeneous persistent moderate enhancement with thickening blood supply arteries was seen in one malignant case with a long diameter of 150 mm and a thick diameter of 30 mm.

Conclusions: CT enhancement usually shows persistent obvious enhancement, especially in arterial phase, which provides important value for the diagnosis. CT findings can help in the differential diagnosis of GGT and other submucosal tumors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994361PMC
http://dx.doi.org/10.1186/s12876-022-02241-wDOI Listing

Publication Analysis

Top Keywords

benign cases
16
cases
9
computed tomography
8
tomography features
8
gastric glomus
8
glomus tumor
8
submucosal tumors
8
heterotopic pancreas
8
malignant case
8
obvious enhancement
8

Similar Publications

We have incidentally observed a finding not yet described in the literature, on both cross-sectional imaging and fluoroscopy, to correlate with increased obstructive symptoms in our post sleeve gastrectomy patients. This case series aims to show postsurgical imaging cases with the common underlying finding of a pseudotumor associated with hiatal herniae and obstructive symptoms. Because this clinical presentation may, in some cases, warrant postsurgical revision, knowledge of the imaging findings and their potential clinical significance is useful to radiologists who interpret routine cross-sectional imaging examinations as well as fluoroscopic evaluations of these post sleeve gastrectomy patients.

View Article and Find Full Text PDF

Central Pancreatectomy as a Surgical Alternative for Parenchyma Preservation.

Cureus

December 2024

Department of Hepatobiliary and Pancreatic Surgery, Pontificia Universidad Católica de Chile, Santiago, CHL.

Pancreatoduodenectomy and distal pancreatectomy are standard treatments for various pancreatic pathologies. These procedures involve radical resection and a significant loss of pancreatic tissue, which can lead to exocrine and/or endocrine pancreatic insufficiency. In selected cases of benign tumors or those with low malignant potential, central pancreatectomy can be performed with acceptable morbidity and mortality rates.

View Article and Find Full Text PDF

Nephrogenic adenoma of the urinary bladder is a rare, benign lesion associated with prior inflammation or irritation of the urothelium. Although typically benign, nephrogenic adenoma can present diagnostic challenges due to its potential to mimic malignant tumors of the urinary tract. In this report, we present a case of an elderly woman with a history of recurrent urinary tract infections and bladder stone surgery who developed nephrogenic adenoma.

View Article and Find Full Text PDF

Sclerosing Mesenteritis Presenting as Intestinal Occlusion: A Case Report.

Cureus

December 2024

Esophagogastric Surgery, Unidade Local de Saúde (ULS) de Viseu Dão-Lafões, Viseu, PRT.

Sclerosing mesenteritis is a chronic disease that primarily affects the mesenteric adipose tissue and encompasses a range of fibrotic and inflammatory pathologies. Due to its low incidence, the etiology remains unclear, though various factors are thought to contribute to its onset. Clinical manifestations are nonspecific, ranging from asymptomatic cases to persistent abdominal pain, which is the most common symptom.

View Article and Find Full Text PDF

Male Breast Cancer Biology, Screening, Treatment, and Follow-Up: A Narrative Review.

Iran J Public Health

December 2024

Research Center of Integrative Medicine, Ageing Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Male breast cancer (MBC) is a rare type of cancer that affects men, accounting for only 1% of all cancers in men and all breast cancer cases worldwide. Its rarity is due to the differences in male endocrine function and the smaller amount of mammary tissue in males. Due to its infrequency, there is limited knowledge about the disease, and treatment recommendations are often based on extrapolation from clinical trial data involving female breast cancer patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!